Ultrasound-targeted microbubble destruction (UTMD) in combination with granulocyte colony-stimulating factor (G-CSF) improves cardiac function in myocardial infarction rats

被引:0
|
作者
Xue, Jing [1 ,2 ]
Yuan, Jian-Jun [1 ]
Deng, Tao [3 ]
Zhang, Zhou-Long [2 ]
Chen, Sheng-Jiang [2 ]
机构
[1] Zhengzhou Univ, Peoples Hosp, Dept Ultrasound, 7 Wei Wu Rd, Zhengzhou 450003, Peoples R China
[2] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Ultrasound, Luoyang 471003, Peoples R China
[3] Henan Univ Sci & Technol, Affiliated Hosp 3, Dept Plast Surg, Luoyang 471003, Peoples R China
关键词
Ultrasound-targeted microbubble destruction; granulocyte colony-stimulating factor; myocardial infarction; cardiac function; vascular endothelial growth factor; VENTRICULAR DIASTOLIC FUNCTION; STEM-CELL TRANSPLANTATION; VASCULOGENESIS; ANGIOGENESIS; IRISIN; MICE; HEMATOPOIESIS; DOPPLER; HUMANS; REPAIR;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objectives: The aim of this study is to determine the effect of ultrasound-targeted microbubble destruction in combination with granulocyte colony-stimulating factor (G-CSF) on revascularization and cardiac function in myocardial infarction rats. Materials and Methods: A total of 40 Wistar rats were successfully constructed as myocardial infarction (MI) model and randomly divided into four groups. Group A, B, C, and D were treated for two weeks with ultrasound, microbubble and G-CSF (UTMD+G-CSF), or ultrasound and microbubble (UTMD), or G-CSF, or surgery control (SC), respectively. Then, the expression of myocardial CD34 was analyzed by immunohistochemistry (IHC) method; the level of microvessel density (MVD) in myocardium was counted; the expression of myocardial vascular endothelial growth factor (VEGF) and Irisin were detected by enzyme linked immunosorbent assay (ELISA), Western blot and quantitative real-time PCR (qPCR) assay. Additionally, cardiac function tests were conducted by echocardiography in all MI rats. Results: Serum Irisin levels of all the MI rats were significantly lower than the control, which indicated the successful construction of MI model. Significant differences (P < 0.05) between group A and other groups were obtained in this study. Massive expression of CD34, with the most obvious neovascularization (MVD: 231.20 +/- 24.48), was observed in group A by IHC; meanwhile, the highest expression of myocardial VEGF (3.23 +/- 0.21 ng/g) and Irisin (607.4 ng/mL) were measured by ELISA, which was confirmed by Western blot and qPCR assays, as the brightest band in group A was observed. Comparison of the left heart function revealed that increased ejection fraction (EF%) (56.78 +/- 7.23) and fractional shortening (FS) (28.23 +/- 4.98%) with decreased TDI-Tei (0.43 +/- 0.11) were appeared in group A when compared with other groups. Conclusions: Combined treatment of ultrasound-targeted microbubble destruction and G-CSF administration can promote revascularization and improve cardiac function in myocardial infarction rats.
引用
收藏
页码:1748 / 1755
页数:8
相关论文
共 50 条
  • [21] Human Milk is an Enteral Source of Granulocyte Colony-Stimulating Factor (G-CSF)
    M Lunoea
    D A Calhounb
    Y Dub
    R D Christensenb
    Pediatric Research, 1999, 45 : 916 - 916
  • [22] Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury
    Khorasanizadeh, MirHojjat
    Eskian, Mahsa
    Vaccaro, Alexander R.
    Rahimi-Movaghar, Vafa
    CNS DRUGS, 2017, 31 (11) : 911 - 937
  • [23] GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AND GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) IN SERUM IN BONE-MARROW TRANSPLANTED PATIENTS
    SALLERFORS, B
    OLOFSSON, T
    LENHOFF, S
    BONE MARROW TRANSPLANTATION, 1991, 8 (03) : 191 - 195
  • [24] DISSOCIATION OF THE PROLIFERATION AND DIFFERENTIATION STIMULI OF GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF)
    IRVINE, AE
    BERNEY, JJ
    FRANCIS, GE
    LEUKEMIA, 1990, 4 (03) : 203 - 209
  • [25] Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo
    Xu, SY
    Höglund, M
    Håkansson, L
    Venge, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) : 848 - 853
  • [26] Current state and future opportunities in granulocyte colony-stimulating factor (G-CSF)
    Hartmut Link
    Supportive Care in Cancer, 2022, 30 : 7067 - 7077
  • [27] Granulocyte colony-stimulating factor (G-CSF) mediates bone resorption in periodontitis
    Yu, Hui
    Zhang, Tianyi
    Lu, Haibin
    Ma, Qi
    Zhao, Dong
    Sun, Jiang
    Wang, Zuomin
    BMC ORAL HEALTH, 2021, 21 (01)
  • [28] GRANULOCYTE COLONY-STIMULATING FACTOR (G-CSF) TREATMENT IN CHRONIC CHAGAS DISEASE: PRESERVATION AND IMPROVEMENT OF CARDIAC STRUCTURE AND FUNCTION
    Soares, M. B. P.
    Macambira, S. G.
    Vasconcelos, J. F.
    Klein, W.
    Costa, C. R. S.
    Vidal, D. T. A.
    Santos, R.
    EXPERIMENTAL HEMATOLOGY, 2009, 37 (09) : S91 - S91
  • [29] Safe administration of granulocyte colony-stimulating factor (G-CSF) to a patient with G-CSF–producing multiple myeloma
    Taku Kikuchi
    Jun Kato
    Yuya Koda
    Masatoshi Sakurai
    Yuichiro Hayashi
    Takehiko Mori
    Annals of Hematology, 2020, 99 : 1667 - 1668
  • [30] Serum levels of granulocyte colony-stimulating factor (G-CSF) and macrophage colony-stimulating factor (M-CSF) in pancreatic cancer patients
    Groblewska, Magdalena
    Mroczko, Barbara
    Wereszczynska-Siemiatkowska, Urszula
    Mysliwiec, Piotr
    Kedra, Boguslaw
    Szmitkowski, Maciej
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2007, 45 (01) : 30 - 34